Because of your expertise in the Biotechnology arena (to be specific in the Cancer arena), what is your take on GILD?
I am holding it for now (down from where I bought it). Many analysts have a "Strong Buy" recommendation on it -- with Target of upto $58-60 range per share.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.